Putin and Xi discuss life-extension prospects as longevity biotech funding soars
Vladimir Putin and Xi Jinping recently debated the possibility of extending human lifespan to 150 years, highlighting Russia's multibillion-dollar support for organ-transplant research and a surge in longevity biotech investment.
During a recent exchange, Vladimir Putin and Xi Jinping debated whether contemporary medicine could finally realize the age-defying ambition long imagined in myth and religion. Putin cited Russia's multibillion-dollar investment in organ-transplant and regenerative-medicine programs, while Xi expressed cautious optimism about forecasts that humans might reach 150 years this century. Their remarks coincide with a rapid expansion of longevity biotechnology, a sub-field that targets the biological mechanisms of aging to boost healthspan and lifespan.
In the first quarter of 2026, companies in this sector raised about $3.74 billion, spurred by advances in AI and the commercial triumph of new obesity drugs. Scientists are mapping the twelve “hallmarks of aging” and testing gene-editing and DNA-repair strategies in animal models, but the FDA does not yet classify aging as a disease, meaning trials must focus on specific health outcomes. Critics warn that manipulating fundamental processes could cause unforeseen side effects, suggesting any real breakthroughs may be many years away.
Why it matters
Longevity biotech could transform health and economies, yet scientific and regulatory hurdles mean practical outcomes are still uncertain.
In this story
